Supporting a Chief Medical Officer

Challenge A listed biotech company conducting Phase III clinical trials in an oncology indication needed Chief Medical Officer support for multiple clinical activities in Europe and the United States.
Learn More

Advising a Chief Medical Officer

Challenge An oncology-focused biopharma company needed support to develop a pipeline of kinase inhibitors in early- and late-stage development.
Learn More

Defining a clinical strategy in oncology

Challenge: A venture capital-backed platform technology company wanted to develop its internal pipeline of therapeutic oncology candidates, while allowing prospective partners to access the...
Learn More

Providing expertise through an oncology scientific advisory board

Challenge An emerging drug discovery company, with a core expertise in molecular modelling, had developed a small molecule inhibitor for a novel cancer metabolism target. The company was looking to...
Learn More

Assessing antibody targets and IP risk

Challenge A mid-cap pharma company seeking to establish a biologics pipeline through partnership with a monoclonal antibody development boutique needed an assessment of target opportunities,...
Learn More

Advising educational institutions on technology transfer

Challenge A university in a developing country wanted advice on best practice for IP protection and technology transfer. Alacrita was engaged to develop a plan for provision of these services.A...
Learn More

Commercial attractiveness of biomarkers for a start-up

Challenge A start-up that had developed a suite of proprietary antibody technologies needed help to identify accessible cell surface proteins for discovery of candidate therapeutic monoclonal...
Learn More

Conducting IP due diligence

Challenge We have conducted multiple due diligence projects, below are three examples:
Learn More

Immunotherapy strategy for a radiotherapy company

Challenge A major player in the radiation oncology market was looking for growth opportunities and had identified cancer immunotherapy as a potential opportunity, given the increasing evidence that...
Learn More

Oncology development plan to support fundraising

Challenge The technology transfer function of a leading cancer research institute needed a development plan for a promising small molecule lead series against a novel anti-invasion/anti-metastasis...
Learn More

Neuroscience Due Diligence

Alzheimer's due diligence Our client, a major pension fund, was considering an investment opportunity in a Phase III neuroscience company. The company was developing a small molecule to provide...
Learn More

510(k) consulting for respiratory medical device

Alacrita's 510(k) regulatory affairs consultant worked with our UK medical device client to secure 510(k) clearance to for a non-contact respiratory measurement device. She provided strategic...
Learn More